1. Clinical Pharmacology Overview From the Antiviral Perspective 2. Outline Terminology Bioequivalence Scenarios with antiretroviral drugs New formulations Alternative dosing…

Slide 1New concepts in HIV Immunology Pr Brigitte AUTRAN Lab. Immunité et Infections, INSERM U945 Institut Fédératif de Recherches Immunité-Cancer-Infection Hôpital…

Slide 1Development of Pediatric ARV Drugs – FDA Perspective Linda L. Lewis, M.D. Medical Officer Division of Antiviral Drug Products U.S. Food and Drug Administration Slide…

1.HIV CLINICAL ISSUESfor Case Managers ADVANCED HIV CASE MANAGEMENTCOURSELeonard A. Sowah, MBChB, MPH Assistant Professor of MedicineInstitute of Human VirologyUniversity…

1.Division of Gastroenterology Duke University Medical Center Hepatitis C Update Andrew Muir, MD Director of Hepatology2. U .S. A.4 M SOUTH AMERICA 10 M AFRICA32 M EASTMEDITERRANEAN…

Dia 1 Scaling up testing and counselling as it looks from treatment data monitoring perspectives: The applied research outcomes and the policy implications it generates –…

1. CROI 2014: ARV and other issues of interest Richard Haubrich, MD Professor of Medicine Division of Infectious Diseases Director, California Collaborative Treatment Group…

1. Management of Occupational Exposure to BBV Dr. Faisal Al Hadad Consultant of Family Medicine & Occupational Health (ABFM, SBFM, MSc Occupational Health (UK Incharge…

HIV Pathogenesis Corrections Curriculum Development: Module 2 Albany Medical College Division of HIV Medicine Pathogenesis Definition: The development of morbid conditions…

MIGUEL A SANZ, MD Valencia, Spain Professor and Head of Department, of Oncology, Hematology and Bone Marrow Transplant Unit, University Hospital La Fe in Valencia, Spain…